News from the Institute

 IBC2 director Ivan Dikic has been awarded with an Advanced Investigator Grant of the European Research Council (ERC). It is the second time that Dikic receives the prestigious grant which entails funding in the amount of € 2.5 million for the next five years.
Within his new project, Dikic is investigating how bacteria manipulate the ubiquitin system of their host organism. "Bacteria are rapidly changing chemical factories that subdue human cells and exploit them for their own needs. We focus on foodborne pathogens such as Salmonella, Escherichia coli and Shigella that cause around 200 million infections and more than 250.000 deaths per year”, explains Dikic. “We will investigate how bacterial toxins containing different enzymatic activities cause cell and tissue damages, eventually resulting in symptoms of infection.”

Timurs Maculins, postdoctoral scientist in the group of Ivan Dikic at IBC2, was awarded a 2-year postdoctoral fellowship by the AXA Research Fund. The funded project will focus on how pathogenic bacteria hijack the host cell and suppress its immune response, ultimately aiming at finding new antibiotics.
The AXA Research Fund grants 25 postdoctoral fellowships annually for postdoctoral researchers and is dedicated to boosting scientific discoveries that contribute to societal progress. It was established in 2007 and has since then supported more than 500 research projects, hosted in 34 countries, aiming to foster research on risks and challenges today’s societies are faced by.

Ubiquitin molecules can be attached to each other to build longer chains with unique 3D structures mediating diverse functions. About a decade ago, linear ubiquitin chains, in which the head of one ubiquitin is linked to the tail of another, were identified as a new chain type involved in inflammatory signalling.

However, target proteins of linear ubiquitination and their specific functions have largely remained elusive. A novel technology developed by an international team around IBC2 group leader Koraljka Husnjak now enables the systematic analysis of linear ubiquitination targets. Details are published in today’s online issue of Nature Methods.

Christian Münch, group leader at the IBC2, contributed to a study recently published in Nature. The work was led by Dipanjan Chowdhury at the Dana-Farber/Harvard Cancer Center and described the role of an uncharacterized protein – TIRR – in regulating DNA double-strand repair. TIRR binds to the tandem Tudor domain of 53BP1, a protein important for DNA double-strand repair, masking the histone methyl-lysine binding motif on 53BP1 and preventing chromatin binding. Also, TIRR stabilizes the nuclear-soluble 53BP1 fraction through direct binding. Through these mechanisms, TIRR affects 53BP1 activity and DNA double-strand repair efficiency.

The award ceremony for the 2016 Competition on International Research Marketing Ideas by the German Research Foundation (DFG) took place on 16th Feb 2017 in Potsdam. Besides Goethe University (GU) three other institutions were honored, and the prize was handed over by DFG’s Vice President Prof. Roland A. Fischer in a lively ceremony comprising interviews with all awardees.